Clonidine Tablet, Extended Release
Pricing Report NDC 52817-375-30

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The current wholesale acquisition cost for Clonidine (NDC 52817-375-30) is $15.14494 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Trupharma, Llc, this medication is distributed in a 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$15.14494
Per EA

Effective Date
Jun 17, 2026
Billable Units
30 EA
Estimated Package Price
$454.35
Data Status
As of Jul 08, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2024, the NADAC wholesale price for (NDC ) has moved within a range of $12.72800 to $15.14494 per EA. Over this 1 year and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$12.7280 - $15.1449
Market Volatility
18.99% Variance
Latest Trend
1.51%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $15.14494 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2026 $14.91898 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2026 $14.68121 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2026 $14.65686 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2026 $14.58668 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $14.57662 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2025 $14.54507 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2025 $14.59604 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2025 $14.61302 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2025 $14.64700 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $14.64700 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $12.89000 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $12.89000 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Oct 23, 2024 $12.89000 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $12.89000 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Sep 18, 2024 $12.99757 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2024 $12.72800 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 17, 2024 $12.72800 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026